Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company is advancing its CART-ddBCMA product through its... Read more
MarketWatch
MarketWatch
MarketWatch
MarketWatch
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.